Ventana Medical Systems News

TUCSON, Ariz., May 21, 2012 /PRNewswire/ -- Ventana Medical Systems, Inc. , a member of the Roche Group, announced today that it has co-exclusively sub-licensed certain patents and patent applications from Gen-Probe Incorporated for the worldwide in vitro diagnostic rights for measuring ERG protein expression through immunohistochemistry in ... (more)

Ventana Medical Systems, Inc. , a member of the Roche Group, received 510 clearance from the U.S. Food and Drug Administration for the VENTANA Companion Algorithm p53 image analysis application using the VENTANA iScan Coreo Au scanner and VIRTUOSO software.  Currently, Ventana is the only company offering an FDA-cleared p53 image analysis ... (more)

Swiss drug maker Roche Holding AG has gone to court in the US to get its hostile merger target, the US-based diagnostics group Ventana Medical Systems Inc's poison-pill defence provision that allows shareholders to buy new stock at half the price, struck down.

Mumbai: Switzerland's Roche Holding AG, the world's biggest maker of cancer drugs, hinted that it may raise its $3-billion hostile takeover bid for US diagnostics maker Ventana Medical Systems Inc.

With its efforts to negotiate a friendly merger deal with Ventana Medical Systems rebuffed, Swiss pharmaceuticals giant Roche has announced a hostile tender offer to acquire its target for about $3 billion at $75 per share in cash.